Audicin Secures $1.9 Million to Enhance Nervous System Regulation Technology
Audicin, a Finnish neurotech startup, has raised $1.9 million to expand its real-time nervous system regulation technology across consumer and enterprise sectors. The funding aims to accelerate the commercialization of its app, Sleep Headband, and a lightweight SDK for third-party integration.
Theia Market Signal Identification - AI Assisted
Finnish startup Audicin has successfully secured $1.9 million in funding, intended to scale its real-time nervous system regulation technology. This investment will facilitate the rollout of 'Audicin for Apps', a lightweight SDK that allows third-party platforms to integrate passive, biometric-triggered recovery sessions, enhancing user experiences without the need for dedicated wellness time.
Audicin's technology works with wearables like Oura and Apple Watch, adapting recovery sessions based on physiological signals. The company reports an $8 million sales pipeline across sectors such as defense and wellness. With a 69% subscription renewal rate, Audicin has demonstrated strong user retention and revenue growth, indicating a significant demand for its innovative solutions.
Comments